Emerging Trends in Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
The Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market was valued at $144 million in 2016, and is expected to reach $912 million by 2023, registering a CAGR of 30.1% from 2017 to 2023.
The Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market was valued at $144 million in 2016, and is expected to reach $912 million by 2023, registering a CAGR of 30.1% from 2017 to 2023.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Introductionof<br />
<strong>MIGS</strong> <strong>Devices</strong> <strong>Market</strong><br />
The global m<strong>in</strong>imally <strong>in</strong>vasive glaucoma surgery (<strong>MIGS</strong>) devices market was valued at<br />
$144 million <strong>in</strong> 2016, and is projected to reach $912 million by 2023, grow<strong>in</strong>g at a<br />
CAGR of 30.1% from 2017 to 2023. The glaucoma <strong>in</strong> conjunction with cataract surgery<br />
segment accounted for three-fifths share of the market <strong>in</strong> 2016.<br />
M<strong>in</strong>imally <strong>in</strong>vasive glaucoma surgery (<strong>MIGS</strong>) devices are employed <strong>in</strong> the treatment of<br />
glaucoma to provide a safer and less <strong>in</strong>vasive means of reduc<strong>in</strong>g <strong>in</strong>traocular pressure<br />
(IOP) as compared to conventional glaucoma surgery devices. <strong>MIGS</strong> devices are<br />
anticipated to become a preferred surgical modality <strong>in</strong> near future for the treatment of<br />
glaucoma as it reduces dependency on topical medications as well as gets rid of<br />
complications associated to traditional procedures.
Change language